316 related articles for article (PubMed ID: 29151578)
1. Th1 cytokines, true functional signatures for protective immunity against TB?
Zeng G; Zhang G; Chen X
Cell Mol Immunol; 2018 Mar; 15(3):206-215. PubMed ID: 29151578
[TBL] [Abstract][Full Text] [Related]
2. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
3. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
4. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker.
Hadizadeh Tasbiti A; Yari S; Siadat SD; Tabarsi P; Saeedfar K; Yari F
Immunol Res; 2018 Feb; 66(1):59-66. PubMed ID: 29178041
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity.
Ma J; Tian M; Fan X; Yu Q; Jing Y; Wang W; Li L; Zhou Z
Oncotarget; 2016 Sep; 7(39):63804-63815. PubMed ID: 27566581
[TBL] [Abstract][Full Text] [Related]
7. Synergy between Th1 and Th2 responses during
Abebe F
Int Rev Immunol; 2019; 38(4):172-179. PubMed ID: 31244354
[TBL] [Abstract][Full Text] [Related]
8. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
9. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.
Monin L; Griffiths KL; Slight S; Lin Y; Rangel-Moreno J; Khader SA
Mucosal Immunol; 2015 Sep; 8(5):1099-109. PubMed ID: 25627812
[TBL] [Abstract][Full Text] [Related]
10. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
Hovav AH; Bercovier H
Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
[TBL] [Abstract][Full Text] [Related]
11. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
[TBL] [Abstract][Full Text] [Related]
12. Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis.
Scriba TJ; Netea MG; Ginsberg AM
Semin Immunol; 2020 Aug; 50():101431. PubMed ID: 33279383
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
[TBL] [Abstract][Full Text] [Related]
14. First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses.
Ottenhoff TH; Doherty TM; van Dissel JT; Bang P; Lingnau K; Kromann I; Andersen P
Hum Vaccin; 2010 Dec; 6(12):1007-15. PubMed ID: 21178394
[TBL] [Abstract][Full Text] [Related]
15. [Up-to-date understanding of tuberculosis immunity].
Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of Th1-Type Immune Responses to
Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG
J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214
[TBL] [Abstract][Full Text] [Related]
17. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
[TBL] [Abstract][Full Text] [Related]
18. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
[TBL] [Abstract][Full Text] [Related]
19. Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during
Garand M; Goodier M; Owolabi O; Donkor S; Kampmann B; Sutherland JS
Front Immunol; 2018; 9():257. PubMed ID: 29520269
[TBL] [Abstract][Full Text] [Related]
20. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
